Altogether, our results suggest that the level of LPA1 expression at the site of primary tumors might control very early events during the metastasis process of breast cancers and that targeting LPA1 with Debio 0719 has a high therapeutic potential against metastasis formation for breast cancer patients. This evidence concerns the gene LPAR1 and breast carcinoma.